NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ: TTGT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether TechTarget and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Agilysys, Inc. and its executives, following disappointing financial results and a significant stock price drop [1][3]. Financial Performance - On January 21, 2025, Agilysys reported third quarter revenue that was below market expectations and the company's own guidance, leading to a downward revision of its full-year 2025 revenue outlook [3]. - The CEO acknowledged underestimating sales challenges related to the point-of-sale (POS) segment and noted that the year "could have been a lot better" [3]. - Following the announcement, Agilysys's stock price fell by $25.23 per share, or 20.04%, closing at $100.67 per share on January 22, 2025 [3]. Legal Investigation - Pomerantz LLP is actively investigating claims on behalf of Agilysys investors regarding possible securities fraud or other unlawful practices by the company and its officers [1].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Pliant Therapeutics, Inc and its officers or directors [1] Company Developments - On February 7, 2025, Pliant announced a voluntary pause in enrollment and dosing for the BEACON-IPF Phase 2b trial of bexotegrast due to recommendations from the independent Data Safety Monitoring Board [3] - Following this announcement, analysts from Wells Fargo and Citi downgraded Pliant, expressing uncertainty regarding the future of bexotegrast [3] Stock Performance - Pliant's stock price experienced a significant decline, falling by $4.72 per share, or 60.59%, closing at $3.07 per share on February 10, 2025 [4]

MILWAUKEE, April 24, 2025 /PRNewswire/ -- Ademi & Fruchter LLP is investigating possible securities fraud claims against UnitedHealth (NYSE: UNH). The investigation results from inaccurate statements UnitedHealth made regarding its business operations and prospects.Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.The investigation focuses on UnitedHealth's recent revisions ...

Core Viewpoint - A class action lawsuit has been filed against NET Power Inc. for alleged violations of securities laws, specifically related to misleading statements about Project Permian and its financial implications [1][4]. Group 1: Lawsuit Details - The lawsuit is based on allegations that NET Power made false and misleading statements regarding the completion timeline and budget of Project Permian, which were not grounded in reality [4]. - Investors who purchased NET Power securities between June 9, 2023, and March 7, 2025, are encouraged to participate in the lawsuit before the deadline of June 17, 2025 [2]. Group 2: Impact on Investors - The delays and cost overruns associated with Project Permian are expected to negatively impact the company's financial results and overall business performance [4]. - When the market became aware of the true situation regarding NET Power, investors reportedly suffered damages due to the misleading public statements made by the company [4].

Core Viewpoint - A lawsuit has been filed against Atkore Inc. and its senior executives for potential violations of federal securities laws, specifically related to misrepresentations about PVC Pipe pricing and an alleged price-fixing scheme [1][2][5]. Company Overview - Atkore Inc. manufactures electrical, safety, and infrastructure products, including PVC Pipe [3]. Legal Proceedings - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until April 23, 2025, to seek appointment to lead the case [2]. Allegations - Atkore is accused of misrepresenting the reasons for post-pandemic PVC Pipe price declines, attributing them to "pricing normalization" and "competitive dynamics" [4]. - An activist investor report alleged that Atkore engaged in an anticompetitive price-fixing scheme that artificially inflated PVC Pipe prices [5]. Financial Impact - On February 4, 2025, Atkore announced disappointing earnings, revealing a mid-single-digit decline in the plastic pipe and conduit product category, largely attributed to its PVC Pipe business, which accounted for approximately $75 million of the guidance reduction [6]. - Following this announcement, Atkore's stock price fell nearly 20%, from $79.72 per share to $64.13 per share [6]. Regulatory Scrutiny - On February 14, 2025, Atkore disclosed receiving a grand jury subpoena from the U.S. Department of Justice Antitrust Division regarding the pricing of its PVC pipe and conduit products [7].

Core Viewpoint - Movado Group, Inc. is under investigation for possible securities fraud related to misconduct in its Dubai branch, which may lead to a class action lawsuit for affected investors [1][3]. Group 1: Allegations and Misconduct - In late January 2025, Movado became aware of allegations of misconduct within its Dubai branch, which involved improper sales practices affecting customers in the Middle East, India, and Asia Pacific [3]. - The former managing director and certain subordinates engaged in actions that resulted in overstated and prematurely recognized sales, as well as underreported customer discounts [3][4]. - Misconduct included unauthorized use of a third-party warehouse for premature sales recognition and falsification of documents to bypass internal controls, occurring over approximately five years starting from the fiscal year ended January 31, 2021 [4]. Group 2: Financial Restatement and Internal Controls - Movado announced it would restate its consolidated financial statements for the fiscal years ended January 31, 2024, 2023, and 2022, along with interim periods for fiscal years 2025 and 2024, to accurately reflect sales and credits [5]. - The restated financials for 2025 interim periods will also show a reduction in operating expenses due to the reversal of certain accruals linked to the revised results [5]. - A material weakness in the Company's internal control over financial reporting was identified, particularly in the risk assessment process that failed to address the lack of segregation of duties within the Dubai branch [6].

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Movado and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April 11, 2025, ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CarMax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April 10, 2025, CarMa ...

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Agilysys, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers [1] - Agilysys reported third quarter revenue that fell below market expectations and its own guidance, leading to a significant downward revision of its full-year 2025 revenue outlook [3] - Following the disappointing earnings report, Agilysys's stock price dropped by $25.23 per share, or 20.04%, closing at $100.67 per share [3] Company Performance - The third quarter revenue of Agilysys was lower than anticipated, prompting a revision of the full-year revenue outlook [3] - CEO Ramesh Srinivasan acknowledged underestimating sales challenges related to the point-of-sale (POS) segment and indicated that the company could have performed better in hiring for implementation services [3] Legal Investigation - Pomerantz LLP, a firm specializing in corporate and securities class litigation, is leading the investigation into Agilysys for potential securities fraud [1][4] - The firm has a history of recovering significant damages for victims of securities fraud and corporate misconduct [4]